Clinical research progress in autologous hematopoietic stem cell transplantation for malignant lymphoma treatment / 中国肿瘤临床
Chinese Journal of Clinical Oncology
;
(24): 1-7, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-462656
ABSTRACT
High-dose therapy (HDT) combined with autologous hematopoietic stem cell transplantation (AHSCT) is a standard treatment for relapsed or refractory aggressive lymphoma. However, the role of HDT/AHSCT in the first-line treatment of lymphoma remains controversial, and related issues about its application in different subtypes of lymphoma should be addressed. This article brief-ly reviewed the clinical progress in AHSCT for malignant lymphoma treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Clinical Oncology
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS